Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Nakajima ST et al. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). 2007 Contraception pmid:17161118
Guazzelli CA et al. Monthly injectable contraceptive use by adolescents in Brazil: evaluation of clinical aspects. 2007 Contraception pmid:17586136
Fonseca AM et al. Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women. 2007 Clin Drug Investig pmid:17217318
Keramaris NC et al. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. 2007 Climacteric pmid:17852143
Seeger H et al. In vitro effects of tibolone and its metabolites on human vascular coronary cells. 2007 Maturitas pmid:17572028
Abdallah MA et al. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. 2007 Fertil. Steril. pmid:17207794
Dane C et al. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. 2007 Gynecol. Endocrinol. pmid:17701771
Christodoulakos GE et al. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. 2007 Atherosclerosis pmid:16842799
Kuhl H and Wiegratz I Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? 2007 Climacteric pmid:17653961
Hansen A et al. Developments in lupus 2006. 2007 Arthritis Res. Ther. pmid:17634152
Muralidhar KR et al. Measurement of back-scattered radiation from micro multileaf collimator into the beam monitor chamber from a dual energy linear accelerator. 2007 J Med Phys pmid:21157537
Yokozeki T et al. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. 2007 Genes Cells pmid:17352738
Joshi S et al. Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. 2007 BMC Dev. Biol. pmid:17567914
Barton M et al. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17634518
Sherwood A et al. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. 2007 Arterioscler. Thromb. Vasc. Biol. pmid:17541023
Kurtay G and Ozmen B A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:16814449
Syed V et al. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression. 2007 J. Cell. Biochem. pmid:17393432
Fernandez MP et al. An assessment of estrogenic organic contaminants in Canadian wastewaters. 2007 Sci. Total Environ. pmid:17197011
Beksinska ME et al. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception. 2007 Contraception pmid:17519149
Kleinschmidt I et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. 2007 Contraception pmid:17519153
Palin SL et al. Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormone-sensitive lipase in human subcutaneous abdominal adipocytes. 2007 Diabetes Obes Metab pmid:17587400
Kernohan AF et al. Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. 2007 Clin. Endocrinol. (Oxf) pmid:17201798
Enríquez J et al. The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites. 2007 J. Endocrinol. pmid:17535886
Rosenberg L et al. Bone status after cessation of use of injectable progestin contraceptives. 2007 Contraception pmid:18061699
Bjarnason NH et al. The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy. 2007 Climacteric pmid:18049941
Divasta AD et al. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. 2007 J Pediatr Adolesc Gynecol pmid:17868896
Soares CN et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. 2006 Sep-Oct Menopause pmid:16894334
Rachoń D et al. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. 2006 Sep-Oct Menopause pmid:16894332
Batzer FR GnRH analogs: options for endometriosis-associated pain treatment. 2006 Nov-Dec J Minim Invasive Gynecol pmid:17097577
Qoubaitary A et al. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. 2006 Nov-Dec J. Androl. pmid:16837736
Manoharan C et al. The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity. 2006 Nov-Dec Mol. Membr. Biol. pmid:17127621
Bese T et al. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia. 2006 Mar-Apr Int. J. Gynecol. Cancer pmid:16681766
Zegura B et al. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. 2006 Jul-Aug Menopause pmid:16837886
Stranahan D et al. The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis. 2006 Dermatitis pmid:16800278
Quint EH et al. Management quandary. Menstrual issues in a teenager with developmental delay. 2006 J Pediatr Adolesc Gynecol pmid:16472731
Meriggiola MC et al. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. 2006 Hum. Reprod. pmid:16731547
Eigeliene N et al. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. 2006 BMC Cancer pmid:17044944
Arruda CG et al. Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women. 2006 Gynecol. Endocrinol. pmid:17135035
Seeger H et al. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? 2006 Eur. J. Gynaecol. Oncol. pmid:16620055
Morroni C et al. Preferences between injectable contraceptive methods among South African women. 2006 Contraception pmid:16730491
Bortolotti de Mello Jacobucci MS et al. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year. 2006 Contraception pmid:16730490
Maclaughlin EJ et al. Management of age-related osteoporosis and prevention of associated fractures. 2006 Ther Clin Risk Manag pmid:18360603
Mazzoni CJ et al. Molecular polymorphism, differentiation and introgression in the period gene between Lutzomyia intermedia and Lutzomyia whitmani. 2006 BMC Evol. Biol. pmid:17069656
Thunell L et al. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. 2006 Maturitas pmid:16198072
Kwok S et al. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. 2006 Maturitas pmid:16139447
Raobaikady B et al. Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative. 2006 Steroids pmid:16712888
Eilertsen AL et al. Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. 2006 Maturitas pmid:16713143
Genazzani AR et al. Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women. 2006 Neuropsychiatr Dis Treat pmid:19412477
Cagnacci A et al. Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women. 2006 Fertil. Steril. pmid:16806211
Nazeri K et al. Colorectal cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study. 2006 Gynecol. Endocrinol. pmid:17012102